MBZUAI and the Department of Health – Abu Dhabi (DoH) have signed an agreement to collaborate on AI research across genomics, precision medicine, robotics, and AI-powered diagnostics. Signed on October 13, 2025, the MoU aims to drive breakthroughs in disease prevention, early detection, and therapeutics. The partnership seeks to translate AI research into tangible improvements in patient care within Abu Dhabi and beyond. Why it matters: This partnership signifies a major push to establish Abu Dhabi as a leader in biomedical research and AI-driven healthcare innovation.
The Abu Dhabi Department of Health (DoH) has partnered with MBZUAI and Core42 to launch the Global AI Healthcare Academy. The academy will provide AI training to healthcare workers in Abu Dhabi, aiming to improve diagnostics, operational efficiency, and patient care. The initiative includes mass training sessions for up to 100 attendees and customized courses in areas like AI for radiology and cardiology. Why it matters: This partnership signals a strategic push to integrate AI into Abu Dhabi's healthcare system, potentially establishing the emirate as a leader in technology-driven healthcare.
MBZUAI has launched master’s and Ph.D. programs in computational biology, expanding its research into life sciences. This includes projects like AIDO (AI-Driven Digital Organism) and analysis of the Emirati Genome Program. The programs are part of MBZUAI’s School of Digital Public Health and aim to integrate computational biology with precision medicine. Why it matters: This initiative supports the UAE's vision for a knowledge-based economy and its ambition to become a global center for scientific and technological progress in biotechnology and healthcare.
SEHA and MBZUAI have signed an MoU to integrate AI into medical care and enhance clinical expertise. They will collaborate on AI-driven solutions for quantifying COVID-19 infection severity and study its long-term impact on UAE residents. The partnership will also focus on diagnosis and treatment methods for acute kidney injury, coronary artery disease, fetal health, and AI-driven point of care ultrasound. Why it matters: This collaboration between a major healthcare provider and an AI university in the UAE could lead to advancements in AI-driven healthcare solutions and improve patient outcomes.
MBZUAI has announced partnerships with IBT and BioMap to advance AI applications in healthcare. The collaboration with IBT will focus on developing personalized digital therapeutics for brain health. The partnership with BioMap will establish a biocomputing innovation research lab in the Middle East focused on AI-generated proteins. Why it matters: These partnerships highlight MBZUAI's commitment to leveraging AI for personalized healthcare solutions and establishing the UAE as a hub for biocomputing innovation.